Bruker Corporation (BRKR)
 NASDAQ: BRKR · Real-Time Price · USD
 36.40
 -1.34 (-3.55%)
  At close: Oct 30, 2025, 4:00 PM EDT
36.39
 -0.01 (-0.03%)
  After-hours: Oct 30, 2025, 7:45 PM EDT
Bruker Market Cap
Bruker has a market cap or net worth of $5.52 billion as of October 30, 2025. Its market cap has decreased by -42.20% in one year.
Market Cap 
 5.52B
Enterprise Value 
 7.90B
1-Year Change 
 -42.20%
Ranking 
 Category 
 Stock Price 
$36.40
Market Cap Chart
Since August 4, 2000, Bruker's market cap has increased from $1.23B to $5.52B, an increase of 347.64%. That is a compound annual growth rate of 6.11%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 5.52B | -37.86% | 
| Dec 31, 2024 | 8.89B | -12.62% | 
| Dec 29, 2023 | 10.17B | 1.17% | 
| Dec 30, 2022 | 10.05B | -21.00% | 
| Dec 31, 2021 | 12.73B | 53.55% | 
| Dec 31, 2020 | 8.29B | 5.59% | 
| Dec 31, 2019 | 7.85B | 68.40% | 
| Dec 31, 2018 | 4.66B | -12.70% | 
| Dec 29, 2017 | 5.34B | 57.15% | 
| Dec 30, 2016 | 3.40B | -16.62% | 
| Dec 31, 2015 | 4.07B | 23.26% | 
| Dec 31, 2014 | 3.31B | -0.21% | 
| Dec 31, 2013 | 3.31B | 30.72% | 
| Dec 31, 2012 | 2.53B | 23.02% | 
| Dec 30, 2011 | 2.06B | -24.73% | 
| Dec 31, 2010 | 2.74B | 38.20% | 
| Dec 31, 2009 | 1.98B | 198.73% | 
| Dec 31, 2008 | 662.80M | -52.76% | 
| Dec 31, 2007 | 1.40B | 82.75% | 
| Dec 29, 2006 | 767.70M | 76.48% | 
| Dec 30, 2005 | 435.00M | 20.63% | 
| Dec 31, 2004 | 360.60M | -7.85% | 
| Dec 31, 2003 | 391.30M | 46.66% | 
| Dec 31, 2002 | 266.80M | -70.26% | 
| Dec 31, 2001 | 897.20M | -30.38% | 
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 730.33B | 
| Johnson & Johnson | 449.57B | 
| AbbVie | 397.72B | 
| UnitedHealth Group | 321.75B | 
| AstraZeneca | 257.84B | 
| Novartis AG | 237.42B | 
| Novo Nordisk | 232.34B | 
| Abbott Laboratories | 216.57B |